Works by Nooka, Ajay K.

Results: 65
    1

    Gene expression profiling impacts treatment decision making in newly diagnosed multiple myeloma patients in the prospective PROMMIS trial.

    Published in:
    EJHaem, 2021, v. 2, n. 3, p. 375, doi. 10.1002/jha2.209
    By:
    • Biran, Noa;
    • Dhakal, Binod;
    • Lentzsch, Suzanne;
    • Siegel, David;
    • Usmani, Saad Z.;
    • Rossi, Adriana;
    • Rosenbaum, Cara;
    • Bhutani, Divaya;
    • Vesole, David H.;
    • Rodriguez, Cesar;
    • Nooka, Ajay K.;
    • van Rhee, Frits;
    • Stork‐Sloots, Lisette;
    • de Snoo, Femke;
    • Bhattacharyya, Pritish K.;
    • Dash, Durga Prasad;
    • Zümrütçü, Sena;
    • van Vliet, Martin H.;
    • Hari, Parameswaran;
    • Niesvizky, Ruben
    Publication type:
    Article
    2

    Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.

    Published in:
    Oncologist, 2023, v. 28, n. 12, p. 1055, doi. 10.1093/oncolo/oyad181
    By:
    • Lalonde, Chloe S;
    • Switchenko, Jeffrey M;
    • Behera, Madhusmita;
    • Bilen, Mehmet A;
    • Owonikoko, Taofeek K;
    • Kaufman, Jonathan L;
    • Nooka, Ajay K;
    • Lewis, Colleen M;
    • Hitron, Elise;
    • Collins, Hannah;
    • Judson, Emma C;
    • Alese, Olatunji B;
    • Donald Harvey, R;
    • Carlisle, Jennifer W
    Publication type:
    Article
    3
    4
    5
    6

    Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 6, p. 575, doi. 10.1002/ajh.24351
    By:
    • Jurczyszyn, Artur;
    • Grzasko, Norbert;
    • Gozzetti, Alessandro;
    • Czepiel, Jacek;
    • Cerase, Alfonso;
    • Hungria, Vania;
    • Crusoe, Edvan;
    • Silva Dias, Ana Luiza Miranda;
    • Vij, Ravi;
    • Fiala, Mark A.;
    • Caers, Jo;
    • Rasche, Leo;
    • Nooka, Ajay K.;
    • Lonial, Sagar;
    • Vesole, David H.;
    • Philip, Sandhya;
    • Gangatharan, Shane;
    • Druzd-Sitek, Agnieszka;
    • Walewski, Jan;
    • Corso, Alessandro
    Publication type:
    Article
    7
    8

    Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01120-9
    By:
    • Joseph, Nisha S.;
    • Kaufman, Jonathan L.;
    • Gupta, Vilas A.;
    • Hofmeister, Craig C.;
    • Dhodapkar, Madhav V.;
    • Boise, Lawrence H.;
    • DiCamillo, Sara M.;
    • Roberts, Danielle;
    • Nooka, Ajay K.;
    • Lonial, Sagar
    Publication type:
    Article
    9
    10
    11
    12
    13

    Venetoclax ex vivo functional profiling predicts improved progression-free survival.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00710-9
    By:
    • Gupta, Vikas A.;
    • Matulis, Shannon M.;
    • Barwick, Benjamin G.;
    • Bog, R. Devin;
    • Shebelut, Conrad W.;
    • Shanmugam, Mala;
    • Neri, Paola;
    • Bahlis, Nizar J.;
    • Dhodapkar, Madhav V.;
    • Heffner, Leonard T.;
    • Hofmeister, Craig C.;
    • Joseph, Nisha S.;
    • Lonial, Sagar;
    • Kaufman, Jonathan L.;
    • Jaye, David L.;
    • Nooka, Ajay K.;
    • Boise, Lawrence H.
    Publication type:
    Article
    14

    Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.

    Published in:
    2022
    By:
    • Nooka, Ajay K.;
    • Kaufman, Jonathan L.;
    • Rodriguez, Cesar;
    • Jakubowiak, Andrzej;
    • Efebera, Yvonne;
    • Reeves, Brandi;
    • Wildes, Tanya;
    • Holstein, Sarah A.;
    • Anderson Jr, Larry D.;
    • Badros, Ashraf;
    • Shune, Leyla;
    • Chari, Ajai;
    • Pei, Huiling;
    • Cortoos, Annelore;
    • Patel, Sharmila;
    • Bartlett, J. Blake;
    • Vermeulen, Jessica;
    • Lin, Thomas S.;
    • Richardson, Paul G.;
    • Voorhees, Peter
    Publication type:
    Letter
    15

    Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00494-4
    By:
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Thulasi, Praneetha;
    • Badros, Ashraf Z.;
    • Jeng, Bennie H.;
    • Callander, Natalie S.;
    • Potter, Heather A.;
    • Sborov, Douglas;
    • Zaugg, Brian E.;
    • Popat, Rakesh;
    • Degli Esposti, Simona;
    • Byrne, Julie;
    • Opalinska, Joanna;
    • Baron, January;
    • Piontek, Trisha;
    • Gupta, Ira;
    • Dana, Reza;
    • Farooq, Asim V.;
    • Colby, Kathryn;
    • Jakubowiak, Andrzej
    Publication type:
    Article
    16

    Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0254-0
    By:
    • Schmidt, Timothy M.;
    • Barwick, Benjamin G.;
    • Joseph, Nisha;
    • Heffner, Leonard T.;
    • Hofmeister, Craig C.;
    • Bernal, Leon;
    • Dhodapkar, Madhav V.;
    • Gupta, Vikas A.;
    • Jaye, David L.;
    • Wu, Jiayi;
    • Goyal, Subir;
    • Chen, Zhengjia;
    • Boise, Lawrence H.;
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Kaufman, Jonathan L.
    Publication type:
    Article
    17
    18

    Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 9, p. 2071, doi. 10.3109/10428194.2015.1128542
    By:
    • Jurczyszyn, Artur;
    • Olszewska-Szopa, Magdalena;
    • Hungria, Vania;
    • Crusoe, Edvan;
    • Pika, Tomas;
    • Delforge, Michel;
    • Leleu, Xavier;
    • Rasche, Leo;
    • Nooka, Ajay K.;
    • Druzd-Sitek, Agnieszka;
    • Walewski, Jan;
    • Davila, Julio;
    • Caers, Jo;
    • Maisnar, Vladimir;
    • Gertz, Morie;
    • Gentile, Massimo;
    • Fantl, Dorotea;
    • Mele, Giuseppe;
    • Vesole, David H.;
    • Yee, Andrew J.
    Publication type:
    Article
    19

    Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 2, p. 383, doi. 10.3109/10428194.2014.921296
    By:
    • Nastoupil, Loretta J.;
    • Shenoy, Pareen J.;
    • Ambinder, Alex;
    • Koff, Jean L.;
    • Nooka, Ajay K.;
    • Waller, Edmund K.;
    • Langston, Amelia;
    • Seward, Miray;
    • Kaufman, Jonathan L.;
    • Bernal-Mizrachi, Leon;
    • King, Nassoma;
    • Lechowicz, Mary Jo;
    • Lonial, Sagar;
    • Sinha, Rajni;
    • Flowers, Christopher R.
    Publication type:
    Article
    20

    Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 15, p. 2629, doi. 10.1002/cncr.35319
    By:
    • Suvannasankha, Attaya;
    • Bahlis, Nizar;
    • Trudel, Suzanne;
    • Weisel, Katja;
    • Koenecke, Christian;
    • Oriol, Albert;
    • Voorhees, Peter M.;
    • Alonso, Aranzazu A.;
    • Callander, Natalie S.;
    • Mateos, María‐Victoria;
    • Reddy, Nishitha;
    • Hakim, Shawn;
    • LaMacchia, John;
    • Patel, Nashita;
    • Williams, Danaé;
    • Jewell, Roxanne C.;
    • Zhou, Xiangdong;
    • Gupta, Ira;
    • Opalinska, Joanna;
    • Nooka, Ajay K.
    Publication type:
    Article
    21
    22

    Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 23, p. 3746, doi. 10.1002/cncr.34987
    By:
    • Nooka, Ajay K.;
    • Cohen, Adam D.;
    • Lee, Hans C.;
    • Badros, Ashraf;
    • Suvannasankha, Attaya;
    • Callander, Natalie;
    • Abdallah, Al‐Ola;
    • Trudel, Suzanne;
    • Chari, Ajai;
    • Libby, Edward N.;
    • Chaudhry, Maria;
    • Hultcrantz, Malin;
    • Kortüm, K. Martin;
    • Popat, Rakesh;
    • Sborov, Douglas;
    • Hakim, Shawn;
    • Lewis, Eric;
    • Gorsh, Boris;
    • Bhushan, Bharat;
    • McKeown, Astrid
    Publication type:
    Article
    23
    24
    25
    26
    27

    Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study.

    Published in:
    Cancer (0008543X), 2021, v. 127, n. 22, p. 4198, doi. 10.1002/cncr.33809
    By:
    • Lonial, Sagar;
    • Lee, Hans C.;
    • Badros, Ashraf;
    • Trudel, Suzanne;
    • Nooka, Ajay K.;
    • Chari, Ajai;
    • Abdallah, Al‐Ola;
    • Callander, Natalie;
    • Sborov, Douglas;
    • Suvannasankha, Attaya;
    • Weisel, Katja;
    • Voorhees, Peter M.;
    • Womersley, Lynsey;
    • Baron, January;
    • Piontek, Trisha;
    • Lewis, Eric;
    • Opalinska, Joanna;
    • Gupta, Ira;
    • Cohen, Adam D.
    Publication type:
    Article
    28
    29

    Daratumumab in multiple myeloma.

    Published in:
    2019
    By:
    • Nooka, Ajay K.;
    • Kaufman, Jonathan L.;
    • Hofmeister, Craig C.;
    • Joseph, Nisha S.;
    • Heffner, Thomas L.;
    • Gupta, Vikas A.;
    • Sullivan, Harold C.;
    • Neish, Andrew S.;
    • Dhodapkar, Madhav V.;
    • Lonial, Sagar
    Publication type:
    journal article
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components.

    Published in:
    Transfusion, 2022, v. 62, n. 7, p. 1365, doi. 10.1111/trf.16987
    By:
    • Snyder, Edward L.;
    • Wheeler, Allison P.;
    • Refaai, Majed;
    • Cohn, Claudia S.;
    • Poisson, Jessica;
    • Fontaine, Magali;
    • Sehl, Mary;
    • Nooka, Ajay K.;
    • Uhl, Lynne;
    • Spinella, Philip;
    • Fenelus, Maly;
    • Liles, Darla;
    • Coyle, Thomas;
    • Becker, Joanne;
    • Jeng, Michael;
    • Gehrie, Eric A.;
    • Spencer, Bryan R.;
    • Young, Pampee;
    • Johnson, Andrew;
    • O'Brien, Jennifer J.
    Publication type:
    Article
    39
    40

    Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 6, p. 2227, doi. 10.1111/bjh.19386
    By:
    • Nooka, Ajay K.;
    • Kaufman, Jonathan L.;
    • Rodriguez, Cesar;
    • Jakubowiak, Andrzej;
    • Efebera, Yvonne;
    • Reeves, Brandi;
    • Wildes, Tanya M.;
    • Holstein, Sarah A.;
    • Anderson, Larry D.;
    • Badros, Ashraf;
    • Shune, Leyla;
    • Chari, Ajai;
    • Pei, Huiling;
    • Cortoos, Annelore;
    • Patel, Sharmila;
    • Lin, Thomas S.;
    • Voorhees, Peter M.;
    • Usmani, Saad Z.;
    • Richardson, Paul G.
    Publication type:
    Article
    41
    42

    Health‐related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 561, doi. 10.1111/bjh.17321
    By:
    • Hungria, Vania;
    • Beksac, Meral;
    • Weisel, Katja C.;
    • Nooka, Ajay K.;
    • Masszi, Tamas;
    • Spicka, Ivan;
    • Munder, Markus;
    • Mateos, María‐Victoria;
    • Mark, Tomer M.;
    • Qi, Ming;
    • Qin, Xiang;
    • Fastenau, John;
    • Spencer, Andrew;
    • Sonneveld, Pieter;
    • Garvin, Wendy;
    • Renaud, Thomas;
    • Gries, Katharine S.
    Publication type:
    Article
    43
    44
    45

    Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15051-z
    By:
    • Bajpai, Richa;
    • Sharma, Aditi;
    • Achreja, Abhinav;
    • Edgar, Claudia L.;
    • Wei, Changyong;
    • Siddiqa, Arusha A.;
    • Gupta, Vikas A.;
    • Matulis, Shannon M.;
    • McBrayer, Samuel K.;
    • Mittal, Anjali;
    • Rupji, Manali;
    • Barwick, Benjamin G.;
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Boise, Lawrence H.;
    • Nagrath, Deepak;
    • Shanmugam, Mala
    Publication type:
    Article
    46
    47

    Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.

    Published in:
    2020
    By:
    • Farooq, Asim V.;
    • Degli Esposti, Simona;
    • Popat, Rakesh;
    • Thulasi, Praneetha;
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Jakubowiak, Andrzej;
    • Sborov, Douglas;
    • Zaugg, Brian E.;
    • Badros, Ashraf Z.;
    • Jeng, Bennie H.;
    • Callander, Natalie S.;
    • Opalinska, Joanna;
    • Baron, January;
    • Piontek, Trisha;
    • Byrne, Julie;
    • Gupta, Ira;
    • Colby, Kathryn
    Publication type:
    Correction Notice
    48

    Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.

    Published in:
    Ophthalmology & Therapy, 2020, v. 9, n. 4, p. 889, doi. 10.1007/s40123-020-00280-8
    By:
    • Farooq, Asim V.;
    • Degli Esposti, Simona;
    • Popat, Rakesh;
    • Thulasi, Praneetha;
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Jakubowiak, Andrzej;
    • Sborov, Douglas;
    • Zaugg, Brian E.;
    • Badros, Ashraf Z.;
    • Jeng, Bennie H.;
    • Callander, Natalie S.;
    • Opalinska, Joanna;
    • Baron, January;
    • Piontek, Trisha;
    • Byrne, Julie;
    • Gupta, Ira;
    • Colby, Kathryn
    Publication type:
    Article
    49

    Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. 194, doi. 10.1016/j.clml.2023.11.001
    By:
    • Martin, Thomas G.;
    • Moreau, Philippe;
    • Usmani, Saad Z.;
    • Garfall, Alfred;
    • Mateos, Maria-Victoria;
    • San-Miguel, Jesus F.;
    • Oriol, Albert;
    • Nooka, Ajay K.;
    • Rosinol, Laura;
    • Chari, Ajai;
    • Karlin, Lionel;
    • Krishnan, Amrita;
    • Bahlis, Nizar;
    • Popat, Rakesh;
    • Besemer, Britta;
    • Martfnez-Lopez, Joaquin;
    • Delforge, Michel;
    • Trancucci, Danielle;
    • Pei, Lixia;
    • Kobos, Rachel
    Publication type:
    Article
    50

    MM-078: Characterization of Ocular Adverse Events in Patients Receiving Belantamab Mafodotin (Belamaf) for ≥12 Months: Post Hoc Analysis of DREAMM-2 Study in Relapsed/Refractory Multiple Myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S419, doi. 10.1016/S2152-2650(21)01940-6
    By:
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Thulasi, Praneetha;
    • Badros, Ashraf Z.;
    • Jeng, Bennie H.;
    • Callander, Natalie S.;
    • Sborov, Douglas;
    • Zaugg, Brian E.;
    • Popat, Rakesh;
    • Esposti, Simona Degli;
    • Baron, January;
    • Doherty, Allison;
    • Lewis, Eric;
    • Opalinska, Joanna;
    • Paka, Prani;
    • Piontek, Trisha;
    • Gupta, Ira;
    • Farooq, Asim V.;
    • Jakubowiak, Andrzej
    Publication type:
    Article